A small-sample clinical study revealed that retinol-binding protein 4 (RBP4), a marker used to monitor DKD, may be considered a risk factor correlated with cognitive dysfunction in DKD patients with SBIs. This evidence concerns the gene RBP4 and diabetic kidney disease.